Effects of thiazolidinediones on blood pressure (Q36905154)

17 August 2017

1 reference

title

Effects of thiazolidinediones on blood pressure (English)

1 reference

17 August 2017

Thomas D Giles

1

1 reference

PubMed ID

17686386

17 August 2017

Gary E Sander

series ordinal

2

1 reference

17 August 2017

1 August 2007

1 reference

Current Hypertension Reports

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

4

1 reference

17 August 2017

332-337

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-007-0060-0

17 August 2017

0 references

cites work

Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0060-0

Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0060-0

Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-007-0060-0

Insulin resistance and its treatment by thiazolidinediones

21 January 2018

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function

1 reference

12 December 2020

Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity

1 reference

12 December 2020

The effects of thiazolidinediones on blood pressure levels - a systematic review

1 reference

12 December 2020

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator

1 reference

12 December 2020

Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes

1 reference

12 December 2020

Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.

1 reference

12 December 2020

Nuclear receptors and lipid physiology: opening the X-files

1 reference

12 December 2020

Implications of small reductions in diastolic blood pressure for primary prevention

1 reference

12 December 2020

Effect of ramipril on the incidence of diabetes

1 reference

12 December 2020

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

1 reference

12 December 2020

1 reference

12 December 2020

A meta-analysis of the effect of thiazolidinediones on blood pressure

1 reference

12 December 2020

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

12 December 2020

Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness.

1 reference

12 December 2020

Cardiovascular effects of the thiazolidinediones.

1 reference

12 December 2020

Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells

1 reference

12 December 2020

Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery

1 reference

12 December 2020

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

12 December 2020

Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells

1 reference

12 December 2020

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes

1 reference

12 December 2020

Epidemiology of hypertension and insulin resistance syndrome.

1 reference

12 December 2020

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension

1 reference

12 December 2020

Pioglitazone reduces blood pressure in non-dipping diabetic patients.

1 reference

12 December 2020

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

12 December 2020

Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients

1 reference

12 December 2020

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

12 December 2020

PPAR(gamma) and glucose homeostasis

1 reference

12 December 2020

Expanding the definition and classification of hypertension.

1 reference

12 December 2020

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect

1 reference

12 December 2020

Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats

1 reference

12 December 2020

The mechanisms of action of PPARs

1 reference

12 December 2020

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial

1 reference

12 December 2020

Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance

1 reference

12 December 2020

10.1007/S11906-007-0060-0

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17686386